GenTrust’s Thermo Fisher Scientific TMO Stock Holding History

GenTrust’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-369	Closed	-$211K	–	149
2021 Q3	$211K	Buy	+369	New	+$203K	0.02%	137

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GenTrust's TMO Position: Q4 2021 in Review

GenTrust sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 369 shares — an estimated $211K sold.

GenTrust first reported a position in TMO in Q3 2021 and held it in 1 quarter. The position peaked at $211K in Q3 2021. 2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

GenTrust reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
GenTrust sold 369 Thermo Fisher Scientific shares in Q4 2021, an estimated $211K.
GenTrust first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 1 quarter.
GenTrust's Thermo Fisher Scientific position peaked at $211K in Q3 2021.
2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on GenTrust's 13F filing for Q4 2021, filed 7 Feb 2022.